Placebo Controlled, Dose Response, Safety and Immunogenicity Study of Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-004)
Clinical trial NCT02314923 · COMPLETED
Trial details
- NCT number
- NCT02314923
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-05
- Primary completion
- 2016-06-23
- Enrollment
- 513
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.